Hyperbaric oxygen and basic fibroblast growth factor promote growth of irradiated bone

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 1, 1998, Pages 189-196

  Wang, Xin ^a   Ding, Ivan ^a   Xie, Huchen ^a   Wu, Timothy ^a   Wersto, Nancy ^a   Huang, Kundi ^a   Okunieff, Paul ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Cytokine; FGF; Prevention; Toxicity

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE GROWTH; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HYPERBARIC OXYGEN; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; TIBIA;

ANIMALS; BONE DEVELOPMENT; FEMALE; FIBROBLAST GROWTH FACTOR 2; HINDLIMB; HYPERBARIC OXYGENATION; LEG LENGTH INEQUALITY; MICE; MICE, INBRED C3H; TIBIA;

EID: 0031974286     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00563-4     Document Type: Article

References (54)

1. Abboud S. L., Pinzani M. Peptide growth factors stimulate macrophage colony stimulating factor in murine stromal cells. Blood. 78:1991;103-109.
2. Anscher M. S., Kong F.-M., Murase T., Jirtle R. L. Short communication Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ Br. J. Radiol. 68:1995;331-333.
3. Anscher M. S., Murase T., Prescott D. M., Marks L. B., Reisenbichler M., Bentel G. C., Spencer D., Sherouse G., Jirtle R. L. Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;671-676.
4. Anscher M. S., Peters W. P., Reisenbichler H., Petros W. P., Jirtle R. L. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N. Engl. J. Med. 328:1993;1592-1598.
5. Avraham H., Banu N., Scadden D. T., Abraham F., Groopman J. E. Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood. 83:1994;2126-2132.
6. Barcellos-Hoff M. H., Ehrhart E. J., Kalia M., Jirtle R., Flanders K., Tsang M. L. S. Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am. J. Pathol. 147:1995;1228-1237.
7. Bessler H., Gilgal R., Djaldetti M., Zahavi I. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J. Leukoc. Biol. 40:1986;747-754.
8. Bikfalvi A., Han Z. C., Fuhrmann G. Interaction of fibroblastic growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood. 80:1992;1905-1913.
9. Breuer R., Tochner Z., Conner M. W., Nimrod A., Gorecki M., Or R., Slavin S. Superoxide dismutase inhibits radiation-induced lung injury in hamsters. Lung. 170:1992;19-29.
10. Bruno E., Cooper R. J., Wilson E. L., Gabrilove J. L., Hoffman R. Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood. 82:1993;430-435.
11. Canalis E., Centrella M., McCarthy T. Effects of bsic fibroblast growth factor on bone formation in vitro. J. Clin. Invest. 81:1988;1572-1577.
12. Chen T. L., Chang L. Y., DiGregorio D. A., Perlman A. J., Huang Y.-F. Growth factor modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cells. Endocrinology. 133:1993;1382-1389.
13. Delanian S., Baillet F., Huart J., Lefaix J. L., Maulard C., Housset M. Successful treatment of radiation-induced fibrosis using liposomal Cu/Sn superoxide dismutase clinical trial . Radiother. Oncol. 32:1994;12-20.
14. cH/HeNCr mice. Radiat. Oncol. Invest. 4:1996;9-16.
15. Dion M. W., Hussey D. H., Doornbos J. F., Vigliotti A. P., Wen B. C., Anderson B. Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;401-407.
16. Dion M. W., Hussey D. H., Osborne J. W. The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice. Int. J. Radiat. Oncol. Biol. Phys. 17:1993;101-107.
17. Dische S. Hyperbaric oxygen the Medical Research Council trials and their clinical significance . Br. J. Radiol. 51:1979;888-894.
18. Feldmeier J. J., Helen I., Davolt D. A., Valente P. T., Meltz M. L., Alecu R. Hyperbaric oxygen as a prophylaxis for radiation-induced delayed enteropathy. Radiother. Oncol. 35:1995;138-144.
19. Feldmeier J. J., Lange J. D., Cox S. D., Chou L. J., Ciaravino V. Hyperbaric oxygen as prophylaxis or treatment for radiation myelitis. Undersea Hyperbaric Med. 20:1993;249-255.
20. Franko A. J., Sharplin J. Development of fibrosis after lung irradiation in relation to inflammation and lung function in a mouse strain prone to fibrosis. Radiat. Res. 140:1994;347-355.
21. Fuks Z., Persaud R. S., Alfieri A., McLoughlin M., Ehleiter D., Schwartz J. L., Seddon A. P., Cordon-Cardo C., Haimovitz-Friedman A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54:1994;2582-2590.
22. Haimovitz-Friedman A., Balaban N., McLoughlin M., Ehleiter D., Michaeli J., Vlodavsky I., Fuks Z. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54:1994;2592-2597.
23. Haimovitz-Friedman A., Vlodavasky I., Chaudhuri A., Witte L., Fuks Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res. 51:1991;2552-2558.
24. Hauschka P. V., Mavrakos A. E., Iafrati M. D., Doleman S. E., Klagsbrun M. Growth factors in bone matrix. Isolation of multiple types of affinity chromatography on heparin-Sapharose. J. Biol. Chem. 261:1986;12665-12674.
25. Henk, J. M.; Smith, C. W. Radiotherapy and hyperbaric oxygen in head and neck cancer. Lancet 2-104; 19105. 77.
26. Jirtle R., Clifton K. H. Effect of preirradiation of the tumor bed on the relative vascular space of mouse gastric adenocarcinoma 328 and mammary adenocarcinoma CA755. Cancer Res. 33:1973;764-768.
27. Jirtle R., Rankin J. H. G., Clifton K. H. Effect of x-irradiation of tumour bed on tumour blood flow and vascular response to drugs. Br. J. Cancer. 37:1978;1033-1038.
28. Lefaix J. L., Delanian S., Leplat J. J., Tricaud Y., Martin M., Nimrod A., Baillet F., Daburon F. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD An experimental study . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;305-312.
29. Lian Q. L., Hang R. C., Yan H. F., Chen T., In G. T., Lu H. Q., Liu Y. Y., Liu X. Q. Effects of hyperbaric oxygen on S-180 sarcoma in mice. Undersea Hyperb. Med. 22:1995;153-160.
30. Luk K. H., Baker D. G., Fellows C. F. Hyperbaric oxygen after radiation and its effect on the production of radiation myelitis. Int. J. Radiat. Oncol. Biol. Phys. 4:1978;457-459.
31. Malaker K., Das R. M. The effect of superoxide dismutase on the pathogenesis of radiation-induced pulmonary damage in the rat. Pharmacol. Ther. 39:1988;327-330.
32. Marx R. E., Johnson R. P., Kline S. N. Prevention of osteoradionecrosis A randomized prospective clinical trial of hyperbaric oxygen versus penicillin . JADA. 111:1985;49-54.
33. Masuda A., Longo D. L., Kobayashi Y., Appella E., Oppenheim J. J., Matsushima K. Induction of mitochondrial manganese superoxide dismutase by interleukin 1. FASEB J. 2:1988;3087-3091.
34. Michelson A. M., Puget K., Jadot G. Anti-inflammatory activity of superoxide dismutases Comparison of enzymes from different sources in different models in rats: Mechanism of action . Free Radic. Res. Commun. 2:1986;43-56.
35. Milas L., Ito H., Hunter N., Jones S., Peters L. Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma dependency on tumor type . Cancer Res. 46:1986;723-727.
36. Neta R., Oppenheim J. J., Douches S. D. Interdependence of the radioprotective effects of human recombinant interleukin 1, tumor necrosis factor, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. 140:1988;108-111.
37. Nicolas V., Nefussi J. R., Collin P., Forest N. Effects of acidic fibroblast growth factor and epidermal growth factor on sub-confluent fetal rat calvaria cell cultures DNA synthesis and alkaline phosphatase activity . Bone Miner. 8:1990;145-156.
38. Okunieff P., Abraham E. H., Moini M., Snyder M. L., Gloe T. R., Capogrossi M. C., Ding I. Basic fibroblast growth factor radioprotects bone marrow and not RIF1 tumor. Acta Oncol. 34:1995;435-438.
39. Okunieff P., Dols S., Lee J., Singer S., Vaupel P., Neuringer L. J., Beshah K. Angiogenesis determines blood flow, metabolism, growth rate, and ATPase kinetics of tumors growing in an irradiated bed 31P and 2H nuclear magnetic resonance studies . Cancer Res. 51:1991;3289-3298.
40. Okunieff P., Urano M., Kallinowski F., Vaupel P., Neuringer L. J. Tumors growing in irradiated tissue Oxygenation, metabolic state, and pH . Int. J. Radiat. Oncol. Biol. Phys. 21:1991;667-673.
41. Okunieff P., Wu T., Huang K., Ding I. Differential radioprotection of three mouse strains by basic or acidic fibroblast growth factor. Br. J. Cancer. 74:1996;S105-S108.
42. Rodan S. B., Wesolowski G., Thomas K. A., Yoon K., Rodan G. A. Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect. Tissue Res. 20:1989;283-288.
43. Suit H., Skates S., Taghian A., Okuneiff P., Efird J. Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother. Oncol. 25:1992;251-260.
44. Suit H. D. Hyperbaric oxygen in radiotherapy of four mouse tumors. Proc. Intern. Conf. Radiat. Biol. Cancer. 1:1966;39-43.
45. Suit H. D. Local control and patient survival. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;653-660.
46. Suit H. D., Maimonis P., Michaels H. B., Sedlacek R. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors. Radiat. Res. 87:1981;360-367.
47. Travis E. L., De Luca M., Fowler J. F., Padikal T. N. The time course of radioprotection by WF2721 in mouse skin. Int. J. Radiat. Oncol. Biol. Phys. 8:1982;843-850.
48. Uckun F. M., Gillis S., Souza L., Song C. W. Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;415-435.
49. Uckun F. M., Souza L., Waddick K. G., Wick M., Song C. W. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. Blood. 75:1990;638-645.
50. Urano M., Abe Y. Late reaction following twice-a-day irradiations in murine foot Possible repopulation or consequential late effect . Int. J. Radiat. Oncol. Biol. Phys. 23:1992;847-852.
51. Urano M., Rice L., Cunningham M. Effect of fractionated hyperthermia on normal and tumor tissue in an experimental animal system. Abe M., Sakanoto K., Phillips T. L. Treatment of radioresistant cancers. 1979;43-53 Elesvier/North-Holland Biomedical Press, New York.
52. Watson E. R., Halnan K. E., Dische S., Saunders M. I., Cade I. S., McEwen J. B., Wiernik G., Perrins D. J. D., Sutherland I. Hyperbaric oxygen and radiotherapy A Medical Research Council trial in carcinoma of the cervix . Br. J. Radiol. 51:1978;879-887.
53. Wong G. H. W., Goeddel D. V. Induction of manganous superoxide dismutase by tumor necrosis factor Possible protective mechanism . Science. 242:1988;941-944.
54. Zsebo K. M., Smith K. A., Hartley C. A., Greenblatt M., Cooke K., Rich W., McNiece I. K. Radioprotection of mice by recombinant rat stem cell factor. Proc. Natl. Acad. Sci. USA. 89:1992;9464-9468.